Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN 5541, USA; Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN 55455, USA; Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55455, USA; Center for Cognitive Sciences, University of Minnesota, Minneapolis, MN 55455, USA.
Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN 5541, USA.
EBioMedicine. 2018 Sep;35:288-294. doi: 10.1016/j.ebiom.2018.08.026. Epub 2018 Aug 20.
Age-related brain changes are well-documented and influenced by genetics. Extensive research links apolipoprotein E (apoE) to brain function, with the E4 allele serving as a risk factor for brain disease, including Alzheimer's disease, and the E2 allele conferring protection. Recent evidence also supports protective effects of another gene, human leukocyte antigen (HLA) DRB113, on brain disease and age-related brain atrophy in cognitively healthy adults. Here we investigated the effects of apoE and HLA DRB113 on brain function by examining changes in neural network properties with age in healthy adults.
One hundred seventy-eight cognitively healthy women (28-99 y old) underwent a magnetoencephalography scan and provided a blood sample for genetic analysis. Age-related changes in neural network variability in genetic subgroups of DRB1*13 × apoE genotype combinations were assessed using linear regression of network variability against age.
For individuals lacking a DRB113 allele and/or carrying an apoE4 allele, network variability increased significantly with age. In contrast, no such increase was observed in the presence of DRB113 and/or apoE2.
These findings extend previous research documenting the protective effect of DRB113 on brain structure to include protection against age-related changes in brain function, and demonstrate similar protective effects on neural network variability for either DRB113 or apoE2. These protective effects could be due to reduction or elimination of factors known to disrupt brain function, including neuroinflammation and amyloid beta protein.
U.S. Department of Veterans Affairs, and University of Minnesota.
与年龄相关的大脑变化是有充分记录的,并受遗传因素的影响。大量研究将载脂蛋白 E(apoE)与大脑功能联系起来,E4 等位基因是大脑疾病的风险因素,包括阿尔茨海默病,而 E2 等位基因则具有保护作用。最近的证据还支持另一个基因——人类白细胞抗原(HLA)DRB113——对大脑疾病和认知健康成年人与年龄相关的大脑萎缩的保护作用。在这里,我们通过检查认知健康成年人的大脑功能随年龄的变化,研究了 apoE 和 HLA DRB113 对大脑功能的影响。
178 名认知健康的女性(28-99 岁)接受了脑磁图扫描,并提供了血液样本进行基因分析。使用网络变异性与年龄的线性回归,评估了 DRB1*13×apoE 基因型组合的遗传亚组中,年龄相关的神经网络变异性的变化。
对于缺乏 DRB113 等位基因和/或携带 apoE4 等位基因的个体,网络变异性随年龄显著增加。相比之下,在存在 DRB113 和/或 apoE2 的情况下,没有观察到这种增加。
这些发现扩展了先前记录 DRB113 对大脑结构具有保护作用的研究,包括对大脑功能与年龄相关变化的保护作用,并证明了 DRB113 或 apoE2 对神经网络变异性具有类似的保护作用。这些保护作用可能是由于减少或消除了已知会破坏大脑功能的因素,包括神经炎症和淀粉样β蛋白。
美国退伍军人事务部和明尼苏达大学。